hsa-mir-3202 _LIHC.png
hsa-mir-6820-3p _LIHC.png
ELFN2 _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10018511
Fusion event
HBV-ELFN2 integration
Validated
No
Detection method
VirusFinder
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2017
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1008
End
1867
Integrated sequence
TTTTGGGTTTTGCTGCCCCTTTTACACAATGTGGTTATCCTGCGTTGATGCCTTTGTATGCATGTATTCAATCTAAGCAGGCTTTCACTTTCTCGCCAACTTACAAGGCCTTTCTGTGTAAACAATACCTGAACCTTTACCCCGTTGCCCGGCAACGGCCAGGTCTGTGCCAAGTGTTTGCTGACGCAACCCCCACTGGCTGGGGCTTGGTCATGGGCCATCAGCGCATGCGTGGAACCTTTTCGGCTCCTCTGC
Host Sequence
Chromosome
chr22
Cytoband
q13.1
Reference genome
End
37751589/37355549 (Hg38)
Location type
Intron2
Fragile sites / regions
Target gene
miRNAs that regulate target gene
hsa-mir-1200 ; hsa-mir-1207-5p ; hsa-mir-1225-3p ; hsa-mir-1226-5p ; hsa-mir-1249-5p ; hsa-mir-1250-5p ; hsa-mir-1321 ; hsa-mir-134-5p ; hsa-mir-149-3p ; hsa-mir-1827 ; hsa-mir-1909-3p ; hsa-mir-1910-3p ; hsa-mir-214-3p ; hsa-mir-3064-3p ; hsa-mir-3118 ; hsa-mir-3126-5p ; hsa-mir-3136-5p ; hsa-mir-3141 ; hsa-mir-3151-3p ; hsa-mir-3164 ; hsa-mir-3202 ; hsa-mir-3619-5p ; hsa-mir-3653-5p ; hsa-mir-3915 ; hsa-mir-3928-3p ; hsa-mir-4252 ; hsa-mir-4261 ; hsa-mir-4291 ; hsa-mir-4300 ; hsa-mir-4302 ; hsa-mir-4317 ; hsa-mir-4324 ; hsa-mir-4419a ; hsa-mir-4439 ; hsa-mir-4476 ; hsa-mir-4510 ; hsa-mir-4513 ; hsa-mir-4519 ; hsa-mir-4688 ; hsa-mir-4715-3p ; hsa-mir-4728-5p ; hsa-mir-4739 ; hsa-mir-4746-3p ; hsa-mir-4747-5p ; hsa-mir-4756-5p ; hsa-mir-4763-3p ; hsa-mir-486-3p ; hsa-mir-494-3p ; hsa-mir-512-5p ; hsa-mir-5196-5p ; hsa-mir-544b ; hsa-mir-558 ; hsa-mir-5591-5p ; hsa-mir-595 ; hsa-mir-6087 ; hsa-mir-6090 ; hsa-mir-6127 ; hsa-mir-6129 ; hsa-mir-6130 ; hsa-mir-6133 ; hsa-mir-615-5p ; hsa-mir-636 ; hsa-mir-644a ; hsa-mir-6499-3p ; hsa-mir-6511a-5p ; hsa-mir-663b ; hsa-mir-6721-5p ; hsa-mir-6722-3p ; hsa-mir-6726-5p ; hsa-mir-6731-5p ; hsa-mir-6734-5p ; hsa-mir-6743-5p ; hsa-mir-6755-5p ; hsa-mir-6760-5p ; hsa-mir-6783-5p ; hsa-mir-6785-5p ; hsa-mir-6797-5p ; hsa-mir-6820-3p ; hsa-mir-6824-5p ; hsa-mir-6827-5p ; hsa-mir-6834-5p ; hsa-mir-6855-3p ; hsa-mir-6857-3p ; hsa-mir-6871-5p ; hsa-mir-6875-5p ; hsa-mir-6876-5p ; hsa-mir-6883-5p ; hsa-mir-7108-5p ; hsa-mir-7112-5p ; hsa-mir-7515 ; hsa-mir-761 ; hsa-mir-8085 ; hsa-mir-920 ; hsa-mir-922 ; hsa-mir-9500 ; hsa-mir-4691-5p ; hsa-mir-6792-3p
Nearest miRNA
hsa-mir-1286/Upstream/1068597; hsa-let-7a-3/Downstream/488723;
Upstream sequence
agcccacacctgacctgtcactggcagagggTGCGCTCGCCCTGAGACCCATCAGGAGCACCTGCCGTGGTGGCGAGGTGGAGGTGGTGCTGGCGTCCTA
Downstream sequence
gcggggccatccctgagcacccATCGATTGTGGCCTTGTCTCCCCACCCAAAGGGCTCCCTTCCCAAGTGTTGCCAGGAGCCCCAGCAGACATCTTCTAC
Target sequence
Ggcttcctctcattgtcaagtcccttctcagacctcacctctgca
Reference
Yoo, S., et al. A pilot systematic genomic comparison of recurrence risks of hepatitis B virus-associated hepatocellular carcinoma with low- and high-degree liver fibrosis. BMC Med ,2017, 15(1): 214.
Curate